| Metric | შპს ნეოფარმი + | შპს მედელ საქართველო | შპს თბილისი მედიკ |
|---|---|---|---|
| Growth | |||
| Revenue | ₾16.3m₾13.9m | ₾16.3m₾5.3m | ₾14.8m₾14.3m |
| Revenue growth | 17.4% | 206.5% | 3.5% |
| Profitability | |||
| EBITDA | -₾751k-₾1.2m | ₾5.6m₾2.2m | ₾827k₾1.8m |
| EBITDA margin | -4.6%-8.4% | 34.0%41.9% | 5.6%12.3% |
| Net profit | -₾873k-₾1.3m | ₾5.5m₾2.2m | -₾2.2m₾1.9m |
| Net margin | -5.4%-9.1% | 33.5%41.9% | -14.8%13.2% |
| Balance sheet | |||
| Total assets | ₾5.7m₾6.3m | ₾2.2m₾233k | ₾18.7m₾19.7m |
| Total equity | ₾14k₾887k | ₾797k₾15k | ₾14.2m₾16.3m |
| ROE | -6150.6%-142.2% | 685.3%15402.6% | -15.5%11.6% |